Patent · US Active

Keto-imidazopyridine derivatives as RORc modulators

US9550771B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Benjamin Fauber · Austin, US
Alberto Gobbi · San Francisco, US

Key dates

Filing date	Sep 10, 2014
Grant date	Jan 24, 2017
Priority date	—
Expiry date	Sep 10, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula I or II:or pharmaceutically acceptable salts thereof, wherein R1 is a group of formula (a), (b), (c); (d) or (e):and m, n, X, Y, R1, R2, R3, R4, Rb and Rc are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.